[New post] New Gene Therapy Approach Offers a Potential Long-Term Treatment for Limb-Girdle Muscular Dystrophy 2B

Mindzilla posted: " Washington, DC — Children's National Hospital experts developed a new pre-clinical gene therapy for a rare disorder, known as limb-girdle muscular dystrophy (LGMD) 2B, that addresses the primary cellular deficit associated with this disease. Using a sing" New post on Mindzilla® New Gene Therapy Approach Offers a Potential Long-Term Treatment for Limb-Girdle Muscular Dystrophy 2B by Mindzilla Washington, DC — Children's National Hospital experts developed a new pre-clinical gene therapy for a rare disorder, known as limb-girdle muscular dystrophy (LGMD) 2B, that addresses the primary cellular deficit associated with this disease. Using a single injection of a low dose gene therapy vector, researchers restored the ability of injured muscle fibres to repair […] Read more of this post Mindzilla | January 4, 2022 at 5:24 pm | Tags: genetic mutation, hASM-AAV, LGMD2B, Limb-Girdle Muscular Dystrophy 2B, Muscle degeneration | Categories: Bioresearch, Gene Therapy, Genomics | URL: https://wp.me/pa6vSf-diS Comment    See all comments Unsubscribe to no longer receive posts from Mindzilla®. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://mindzilla.com/newsroom/science/bioresearch/51142/20220104-new-gene-therapy-approach-offers-a-potential-long-term-treatment-for-limb-girdle-muscular-dystrophy-2b/